P300
Showing 26 - 50 of >10,000
Mild-to-moderate Ulcerative Colitis Trial in Worldwide (Faecal Calprotectin Home Test, PRO-2 Scoring)
Active, not recruiting
- Mild-to-moderate Ulcerative Colitis
- Faecal Calprotectin Home Test
- PRO-2 Scoring
-
Brno, Czechia
- +41 more
Nov 4, 2022
HIV-1 Trial in Worldwide (Ad26.Mos4.HIV, Clade C gp140, Placebo)
Completed
- HIV-1
- Ad26.Mos4.HIV
- +2 more
-
Lilongwe, Malawi
- +22 more
Apr 12, 2022
Vasomotor Symptoms Associated With Menopause, Hot Flashes Trial in Worldwide (Elinzanetant (BAY3427080), Placebo)
Active, not recruiting
- Vasomotor Symptoms Associated With Menopause
- Hot Flashes
- Elinzanetant (BAY3427080)
- Placebo
-
Birmingham, Alabama
- +98 more
Feb 2, 2023
Gout, Chronic Kidney Disease (CKD) Trial in Worldwide (Lesinurad, XOI, Placebo)
Terminated
- Gout
- Chronic Kidney Disease (CKD)
- Lesinurad
- +4 more
-
Birmingham, Alabama
- +115 more
Oct 6, 2021
Drug Interaction Trial in Suru Lere (Artemether-lumefantrine, Atazanavir-ritonavir 300/100 mg)
Completed
- Drug Interaction
- Artemether-lumefantrine
- Atazanavir-ritonavir 300/100 mg
-
Suru Lere, Lagos State, NigeriaApin (Aids Prevention Initiatives in Nigeria) clinic, Lagos Univ
Aug 26, 2020
Asthma Trial in Worldwide (dupilumab, Matching )
Recruiting
- Asthma
- dupilumab
- Matching placebo
-
Rolling Hills Estates, California
- +29 more
Mar 18, 2022
Sjogren's Syndrome Trial in Worldwide (Placebo, Nipocalimab, Standard of Care Treatment)
Recruiting
- Sjogren's Syndrome
- Placebo
- +2 more
-
Anniston, Alabama
- +77 more
Aug 18, 2022
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Empagliflozin, Metformin)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- +2 more
-
Toluca Lake, California
- +101 more
Oct 9, 2023
Invasive Pulmonary Aspergillosis Trial in Worldwide (SCY-078, Voriconazole, Oral Placebo Tablets)
Recruiting
- Invasive Pulmonary Aspergillosis
- SCY-078
- +2 more
-
Sacramento, California
- +22 more
Jul 21, 2022
Schizophrenia Trial in Worldwide (PP6M injection Dose 1, PP6M injection Dose 2)
Completed
- Schizophrenia
- PP6M injection Dose 1
- PP6M injection Dose 2
-
Ciudad Autónoma De Buenos Aires, Argentina
- +29 more
Jul 14, 2022
Hereditary Angioedema (HAE) Trial in Worldwide (DX-2930 - 300mg/2wk, DX-2930 - 300mg/4wk, DX-2930 - 150mg/4wk)
Completed
- Hereditary Angioedema (HAE)
- DX-2930 - 300mg/2wk
- +3 more
-
Birmingham, Alabama
- +40 more
May 13, 2021
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Worldwide (parsaclisinib, )
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
- parsaclisinib
- placebo
-
Los Angeles, California
- +52 more
Nov 15, 2022
Lymphoma, Non-Hodgkin Trial in Germany, Puerto Rico, United States (Lenalidomide, Rituximab)
Active, not recruiting
- Lymphoma, Non-Hodgkin
-
Tucson, Arizona
- +114 more
Jan 11, 2023
Brain Health Trial in Surrey (NeuroCatch Platform 2)
Completed
- Brain Health
- NeuroCatch Platform 2
-
Surrey, British Columbia, CanadaHealthTech Connex Centre for Neurology Studies
Mar 22, 2022
Diversion-p64 Post Market Clinical Follow-Up Study to Assess
Completed
- Intracranial Aneurysm
-
Buenos Aires, Argentina
- +25 more
Nov 19, 2020
Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), SZC Placebo)
Recruiting
- Hyperkalemia
- Sodium Zirconium Cyclosilicate (SZC)
- SZC Placebo
-
Huntsville, Alabama
- +355 more
Feb 1, 2023
Atrial Fibrillation (AF), Stroke Trial in Worldwide (Abelacimab, Rivaroxaban)
Active, not recruiting
- Atrial Fibrillation (AF)
- Stroke
- Abelacimab
- Rivaroxaban
-
Huntsville, Alabama
- +93 more
Jan 25, 2023
Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer
Completed
- Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Gastric Cancer Third Line
- Avelumab
- +3 more
-
Denver, Colorado
- +74 more
Nov 6, 2020
EEG and Brain Pulsatility to Novel Stimuli (Electro-PulCe)
Completed
- Healthy Volunteers
- Registration
- Auditive oddball task
-
Tours, FrancePaedopsychiatry department, University Hospital, Tours
Jul 18, 2022
Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, Placebo)
Recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- Placebo
-
Daphne, Alabama
- +56 more
Jan 20, 2023
Atopic Dermatitis Trial in Worldwide (Abrocitinib 200 mg, Dupilumab 300 mg)
Completed
- Atopic Dermatitis
- Abrocitinib 200 mg
- Dupilumab 300 mg
-
Birmingham, Alabama
- +150 more
Jun 9, 2022
Healthy Trial in Tempe (Relacorilant 350mg, Itraconazole, Relacorilant 300mg)
Completed
- Healthy
- Relacorilant 350mg
- +2 more
-
Tempe, ArizonaCelerion
Mar 23, 2020
Schizophrenia Trial in Lyon (Cognitive remediation, psychosocial rehabilitation)
Recruiting
- Schizophrenia
- Cognitive remediation
- psychosocial rehabilitation
-
Lyon, Rhône, Francecentre de réhabilitation - Hôpital le Vinatier
Aug 11, 2022